1. Home
  2. VGI vs MDXH Comparison

VGI vs MDXH Comparison

Compare VGI & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VGI
  • MDXH
  • Stock Information
  • Founded
  • VGI 2012
  • MDXH 2003
  • Country
  • VGI United States
  • MDXH Belgium
  • Employees
  • VGI N/A
  • MDXH N/A
  • Industry
  • VGI Investment Managers
  • MDXH
  • Sector
  • VGI Finance
  • MDXH
  • Exchange
  • VGI Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • VGI 89.5M
  • MDXH 93.1M
  • IPO Year
  • VGI N/A
  • MDXH 2021
  • Fundamental
  • Price
  • VGI $7.91
  • MDXH $1.82
  • Analyst Decision
  • VGI
  • MDXH Strong Buy
  • Analyst Count
  • VGI 0
  • MDXH 2
  • Target Price
  • VGI N/A
  • MDXH $7.00
  • AVG Volume (30 Days)
  • VGI 46.0K
  • MDXH 113.8K
  • Earning Date
  • VGI 01-01-0001
  • MDXH 02-26-2025
  • Dividend Yield
  • VGI 12.66%
  • MDXH N/A
  • EPS Growth
  • VGI N/A
  • MDXH N/A
  • EPS
  • VGI N/A
  • MDXH N/A
  • Revenue
  • VGI N/A
  • MDXH $84,708,000.00
  • Revenue This Year
  • VGI N/A
  • MDXH $28.76
  • Revenue Next Year
  • VGI N/A
  • MDXH $19.91
  • P/E Ratio
  • VGI N/A
  • MDXH N/A
  • Revenue Growth
  • VGI N/A
  • MDXH 33.01
  • 52 Week Low
  • VGI $6.68
  • MDXH $1.55
  • 52 Week High
  • VGI $7.99
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • VGI 65.36
  • MDXH 33.28
  • Support Level
  • VGI $7.70
  • MDXH $1.80
  • Resistance Level
  • VGI $7.94
  • MDXH $1.97
  • Average True Range (ATR)
  • VGI 0.08
  • MDXH 0.07
  • MACD
  • VGI 0.03
  • MDXH -0.01
  • Stochastic Oscillator
  • VGI 89.06
  • MDXH 12.50

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: